These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 32598932)
21. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346 [TBL] [Abstract][Full Text] [Related]
22. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis. Hu H; Li M; Chen B; Guo C; Yang N Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422 [TBL] [Abstract][Full Text] [Related]
23. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition. Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900 [TBL] [Abstract][Full Text] [Related]
24. Rhodojaponin II attenuates kidney injury by regulating TGF-β1/Smad pathway in mice with adriamycin nephropathy. Qiu Y; Zhou J; Zhang H; Zhou H; Tang H; Lei C; Ye C; You C; Chen Y; Wang Y; Xiong J; Su H; Yao G; Zhang C J Ethnopharmacol; 2019 Oct; 243():112078. PubMed ID: 31301369 [TBL] [Abstract][Full Text] [Related]
25. 1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria. Ma J; Zhang B; Liu S; Xie S; Yang Y; Ma J; Deng Y; Wang W; Xu L; Li R; Zhang L; Yu C; Shi W PLoS One; 2013; 8(5):e64912. PubMed ID: 23741418 [TBL] [Abstract][Full Text] [Related]
26. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients. Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405 [TBL] [Abstract][Full Text] [Related]
27. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis. Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525 [TBL] [Abstract][Full Text] [Related]
28. Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis. Otaki Y; Miyauchi N; Higa M; Takada A; Kuroda T; Gejyo F; Shimizu F; Kawachi H Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1376-87. PubMed ID: 18715943 [TBL] [Abstract][Full Text] [Related]
29. Osthole improves an accelerated focal segmental glomerulosclerosis model in the early stage by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-κB-mediated COX-2 expression and apoptosis. Yang SM; Chan YL; Hua KF; Chang JM; Chen HL; Tsai YJ; Hsu YJ; Chao LK; Feng-Ling Y; Tsai YL; Wu SH; Wang YF; Tsai CL; Chen A; Ka SM Free Radic Biol Med; 2014 Aug; 73():260-9. PubMed ID: 24858719 [TBL] [Abstract][Full Text] [Related]
30. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling. Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956 [TBL] [Abstract][Full Text] [Related]
31. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats. Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701 [TBL] [Abstract][Full Text] [Related]
32. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis. Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788 [TBL] [Abstract][Full Text] [Related]
33. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis. Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251 [TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene transfer of TGF-β1 to the renal glomeruli leads to proteinuria. Ghayur A; Liu L; Kolb M; Chawla A; Lambe S; Kapoor A; Margetts PJ Am J Pathol; 2012 Mar; 180(3):940-951. PubMed ID: 22203053 [TBL] [Abstract][Full Text] [Related]
36. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis. Nakatani K; Asai O; Konishi N; Iwano M Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685 [TBL] [Abstract][Full Text] [Related]
37. Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice. Tsai PY; Ka SM; Chao TK; Chang JM; Lin SH; Li CY; Kuo MT; Chen P; Chen A Free Radic Biol Med; 2011 Jun; 50(11):1503-16. PubMed ID: 21376112 [TBL] [Abstract][Full Text] [Related]
38. Protecting glomerulus: role of angiotensin-II type 2 receptor. Patel S; Kulkarni K; Hussain T Clin Sci (Lond); 2022 Oct; 136(20):1467-1470. PubMed ID: 36287192 [TBL] [Abstract][Full Text] [Related]